KucukseymenSCagirciGBayarNSakirA. Vitamin D trials and their limitations. Angiology. 2016. doi:10.1177/0003319716683494.
2.
StokicEKupusinacATomic-NaglicD. Vitamin D and dysfunctional adipose tissue in obesity. Angiology. 2015;66(7):613–618.
3.
DincaMSerbanMCSahebkarA; for Lipid Blood Pressure Meta-analysis Collaboration LBPMC Group. Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2016;107:360–371.
4.
KupusinacAStokicESrdic-GalicB. Determination of WHtR limit for predicting hyperglycemia in obese persons by using artificial neural networks. TEM J. 2012;1(4):270–272.
5.
StokicESrdic-GalicBKupusinacADoroslovackiR. Estimating SAD low limits for the adverse metabolic profile by using artificial neural networks. TEM J. 2013;(2):115–119.
6.
PappaHMBernEKaminDGrandRJ. Vitamin D status in gastrointestinal and liver disease. Curr Opin Gastroenterol. 2008;24(2):176–183.
7.
Pereira-SantosMCostaPRAssisAMSantosCASantosDB. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev. 2015;16(4):341–349.
